Back to 
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
VIVO
Showing 0 of 17 quarters
Position history for CAPTRUST Financial Advisors's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Captrust held 7,397 shares of VIVO (Meridian Bioscience), worth $245,655. Captrust's 13F filings listed VIVO from Q2 2020 to Q4 2022, 11 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of VIVO: Earnest Partners LLC